Abstract:The role of insulin resistance and triglyceride‐glucose index (TyG) has been investigated in cognitive decline and dementia. Based on 17 included studies, patients with cognitive decline had significantly higher levels of TyG index compared to controls. TyG, as a surrogate marker of insulin resistance, could be a potentially useful biomarker in dementia and cognitive decline. Background Cognitive decline and dementia are debilitating conditions that compromise the quality of life and charge the healthcare system with a substantial socioeconomic burden. In this context, emerging evidence supports an association between the triglyceride‐glucose index (TyG), a surrogate insulin resistance marker, and cognitive decline and dementia. Hence, we systematically reviewed the studies assessing the TyG index in patients with cognitive decline and their controls. Methods Online international databases (PubMed, Scopus, Embase, and the Web of Science) were searched comprehensively for studies showing the TyG index in patients with cognitive decline/impairment. Random‐effect meta‐analyses were conducted to calculate the standardized mean difference (SMD), pooled odds ratio (OR), and pooled area under the curve (AUC), in addition to 95% confidence intervals (CIs) for the comparisons of groups. Results Seventeen studies were included in our analysis. Then, we conducted a meta‐analysis, demonstrating that patients with cognitive decline had significantly higher levels of TyG index than those without (SMD 0.83, 95% CI 0.16 to 1.50, p = 0.015). Moreover, our data showed that a 1‐unit increase in the TyG index was associated with higher odds of cognitive decline (adjusted OR [aOR] 2.86, 95% CI 1.49 to 5.50, p = 0.002). Further, we observed that patients in the fourth TyG quartile with higher values of the TyG index than the first quartile presented with more increased cognitive decline (aOR 1.62, 95%CI 1.11 to 2.38, p = 0.013). Finally, pooled AUC data for the diagnostic performance of the TyG index resulted in an overall AUC value of 0.73 (95% CI 0.66 to 0.79). Sensitivity and specificity were also calculated as 0.695 and 0.687, respectively. Conclusion This study supports the clinical utility of the TyG index in patients with cognitive decline and solicits more focused studies to consolidate its usage in clinical settings and real‐world practice.

Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults

Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS)

The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study

The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults

Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population

Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes

Assessing the association between triglyceride-glucose index and atrial fibrillation: a systematic review and meta-analysis

The triglyceride glucose index was U-shape associated with all-cause mortality in population with cardiovascular diseases

The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study

Association between triglyceride glucose index and all-cause mortality in patients with cerebrovascular disease: a retrospective study

Fasting plasma glucose is a stronger predictor of diabetes than triglyceride–glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study

Exploring the Association Between Cognitive Decline and Triglyceride‐Glucose Index: A Systematic Review and Meta‐Analysis

The association between carbohydrate quality index and conventional risk factors of cardiovascular diseases in an Iranian adult population

Association between Triglyceride-Glucose Index and risk of all-cause and cardiovascular mortality in adults with prior cardiovascular disease: a cohort study using data from the US National Health and Nutrition Examination Survey, 2007-2018

Association of Triglyceride Glucose-Derived Indices with Recurrent Events Following Atherosclerotic Cardiovascular Disease

Triglyceride glucose index as a predictor of mortality in middle-aged and elderly patients with type 2 diabetes in the US

Association of triglyceride-glucose index with cardiovascular disease among a general population: a prospective cohort study

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients

Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China

Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study